Product Information
FENOFIBRATE 160 MG TABLET is a generic product labeled by NorthStar Rx LLC, priced at $0.1033 per EA under NDC 72603084101. Its NADAC has been published 41 times since Dec 24, 2025.
FDA first approved this application on Jun 12, 2020. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
160 mg/1
Manufacturer
NorthStar Rx LLCNDC
72603084101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
FENOFIBRATEApproval Type
Generic (ANDA)
FDA Application
ANDA213864FDA Approved
6/12/2020
TE Code
AB
On Market Since
9/29/2025
Pharmacological Classes
Price Statistics
The NADAC for FENOFIBRATE 160 MG TABLET has been published 41 times since Dec 24, 2025, and over the history we have for it it has risen 15.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1033 per EA |
|---|---|
| All-time high | $0.1259 (May 13, 2026) |
| All-time low | $0.0892 (Dec 24, 2025) |
| 52-week high | $0.1259 |
| 52-week low | $0.0892 |
| Median price | $0.1129 |
| Average price | $0.1096 |
| Largest weekly change | +12.5% (Mar 18, 2026) |
| Weeks tracked | 41 |
| Tracking since | Dec 24, 2025 |
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
NorthStar Rx LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
FENOFIBRATE market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Peroxisome Proliferator Receptor alpha Agonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of FENOFIBRATE 160 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for FENOFIBRATE 160 MG TABLET, manufactured by NorthStar Rx LLC, is $0.1033 per EA (NDC 72603084101), effective Sep 30, 2026.
How has the price of FENOFIBRATE 160 MG TABLET changed over time?
Over the history we have for it, the NADAC for FENOFIBRATE 160 MG TABLET has risen 15.8%. It has been tracked across 41 weekly CMS publications since Dec 24, 2025.
What are the highest and lowest recorded NADAC prices for FENOFIBRATE 160 MG TABLET?
Since Dec 24, 2025, the NADAC for FENOFIBRATE 160 MG TABLET has ranged from a low of $0.0892 (Dec 24, 2025) to a high of $0.1259 (May 13, 2026), with a median of $0.1129 per EA.
Are there cheaper alternatives to FENOFIBRATE 160 MG TABLET?
7 manufacturers publish a NADAC-priced product with the same active ingredient and strength as FENOFIBRATE 160 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures FENOFIBRATE 160 MG TABLET?
FENOFIBRATE 160 MG TABLET (NDC 72603084101) is labeled by NorthStar Rx LLC, and CMS classifies it as a generic product.